FertGroup

Reports that name this provider

Fertility Preservation in Brazil

Brazil's first private equity-backed fertility network, performing 12% of all national ART cycles; controls approximately 50–60% of Brazil's embryoscope inventory; deployed AI-powered oocyte morphology scoring (VIOLET platform) across 10-clinic network; standardizing EMR across network

Fertility Technology in Brazil

Largest private equity-backed fertility network (XP Private Equity backing). Handles approximately 12% of all Brazilian IVF cycles across ten clinics. Purchased estimated 50–60% of all EmbryoScope units operating in Brazil. Holds ONA accreditation. First Brazilian fertility network to deploy Future Fertility's VIOLET and MAGENTA AI oocyte assessment platforms across all clinics in April 2024. Piloting automated vitrification technology through collaboration with HOMU.